Benoit Hennion
Chief Executive Officer bei Ipsen Pharma SAS
Profil
Benoit Hennion is currently the Co-Chief Executive Officer at Ipsen Pharma SAS and also serves as the Chairman at Ipsen OOO.
He previously worked as the Managing Director at Ipsen Pharma SAS and as the Executive VP & President-Consumer Healthcare at Ipsen SA. Hennion holds an MBA from ESSEC Business School.
Aktive Positionen von Benoit Hennion
| Unternehmen | Position | Beginn |
|---|---|---|
| Ipsen OOO | Chairman | - |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Chief Executive Officer | 13.05.2017 |
Ehemalige bekannte Positionen von Benoit Hennion
| Unternehmen | Position | Ende |
|---|---|---|
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | - |
| IPSEN | Corporate Officer/Principal | - |
Ausbildung von Benoit Hennion
| ESSEC Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IPSEN | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| Ipsen OOO |
